Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1998-12-14
|
pubmed:abstractText |
Interleukin 6 (IL-6) is a pleiotropic inflammatory cytokine and its role in cancer is not yet clear. The effects of IL-6 on four breast cancer cell lines and normal mammary epithelium, cultured from milk were tested. Four different patterns of response to IL-6 were found depending on the differentiation status of the cells. In normal mammary epithelial cultures, the effects of IL-6 were mainly growth inhibitory, whereas in MCF-7, IL-6 had growth inhibitory and anti-adhesive effects. In T-47D and ZR-75-1 the anti-adhesive effects were prominent although the growth inhibitory effects were not. These anti-adhesive effects were associated with epithelioid to fibroblastoid morphological changes and a local decrease in E-cadherin expression. In the highly invasive cell line MDA-MB-231, which does not express E-cadherin, no effects of IL-6 were seen. IL-6 levels in the serum of 60 breast cancer patients were found to be increased in 27% (16/60) compared to 2% (1/50) in a control group. Furthermore, it was found that altered E-cadherin expression was seen in 69% of the primary tumours, although no significant association was found between raised serum IL-6 levels and altered E-cadherin expression. Finally IL-6 serum levels did not effect the survival of breast cancer patients. The authors therefore implicate IL-6 as a possible factor important in breast cancer progression and metastasis formation, although the clinical significance of this cytokine in breast cancer patients could not be established.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1043-4666
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 1998 Academic Press.
|
pubmed:issnType |
Print
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
720-8
|
pubmed:dateRevised |
2009-11-3
|
pubmed:meshHeading |
pubmed-meshheading:9770334-Breast,
pubmed-meshheading:9770334-Breast Neoplasms,
pubmed-meshheading:9770334-Cadherins,
pubmed-meshheading:9770334-Cell Adhesion,
pubmed-meshheading:9770334-Cell Division,
pubmed-meshheading:9770334-Epithelial Cells,
pubmed-meshheading:9770334-Female,
pubmed-meshheading:9770334-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:9770334-Growth Inhibitors,
pubmed-meshheading:9770334-Humans,
pubmed-meshheading:9770334-Interleukin-6,
pubmed-meshheading:9770334-Neoplasm Proteins,
pubmed-meshheading:9770334-Tumor Cells, Cultured
|
pubmed:year |
1998
|
pubmed:articleTitle |
The effects of IL-6 on cell adhesion and e-cadherin expression in breast cancer.
|
pubmed:affiliation |
Molecular and Cell Biology Laboratory, Icelandic Cancer Society, P.O. Box 5420, Reykjavik, Iceland.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|